Skip to main content
Medexus Pharmaceuticals Inc. logo

Medexus Pharmaceuticals Inc. — Investor Relations & Filings

Ticker · MDP ISIN · CA58410Q2036 LEI · 8945002TBEYY0HLH1M19 TSX Manufacturing
Open in API
Filings indexed 638 across all filing types
Latest filing 2025-01-31 Regulatory Filings
Country CA Canada
Listing TSX MDP

About Medexus Pharmaceuticals Inc.

https://www.medexus.com/en_US

Medexus Pharmaceuticals, Inc. is an innovative specialty pharmaceutical company engaged in the development and commercialization of treatment solutions. The company utilizes a highly scalable North American business model, leveraging a fully integrated infrastructure encompassing commercial operations, supply chain, regulatory affairs, and a dedicated salesforce. Medexus focuses on building a portfolio of specialty and rare disease products across key therapeutic areas, including hematology, hematology-oncology, allergy, dermatology, and rheumatology. Its mission is to deliver quality healthcare products to patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2025-01-31 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 80% confidence The document is a letter from PwC providing auditor’s consent for inclusion of their audit report in a short form base shelf prospectus supplement relating to the sale and issue of common shares. It is not itself an earnings release, annual/quarterly report, share issuance announcement with terms, or management/board change notice. It is part of a securities offering filing (prospectus), but no specific category for a prospectus consent letter exists. Therefore, it falls into the fallback category for miscellaneous regulatory filings.
2025-01-29 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 80% confidence The document is a legal counsel’s consent letter addressed to Canadian securities regulators consenting to references and opinions in a Prospectus Supplement for a new offering of common shares. It is part of the regulatory filing process (Prospectus Supplement filed via SEDAR+) rather than an earnings release, management report, or board change. There is no specific category for prospectus filings, so this is best classified as a general regulatory filing (RNS).
2025-01-29 English
Underwriting or agency agreements (or amendment thereto).pdf
Capital/Financing Update Classification · 85% confidence The document is a detailed Underwriting Agreement relating to the issuance of 7,500,000 common shares (with an overallotment option) and the terms by which underwriters will purchase and distribute those shares. It is a contractual financing arrangement directly tied to the company raising capital. This falls squarely under Capital/Financing Update (CAP) rather than being an announcement or simple notice of share issuance (SHA) or an annual/interim report. Thus the correct classification is CAP.
2025-01-29 English
Prospectus (non pricing) supplement (other than ATM) – English.pdf
Capital/Financing Update Classification · 87% confidence The document is a Prospectus Supplement to a Short Form Base Shelf Prospectus describing an equity offering of 7,500,000 common shares, the underwriting agreement, offering price, plan of distribution, use of proceeds, etc. It is a detailed financing document associated with a public share issuance. According to the definitions, this is an update on the company’s fundraising and capital structure change, which falls under Capital/Financing Update (CAP).
2025-01-29 English
Consent letter of underwriters' legal counsel.pdf
Regulatory Filings Classification · 85% confidence The document is a legal consent letter from counsel to reference their opinion in a prospectus supplement for a shelf offering. It is not a financial report, earnings, management change, or dividend notice, nor is it a proxy statement, M&A announcement, or share repurchase. It is a miscellaneous regulatory filing associated with securities registration on SEDAR and thus falls under the catch-all category for general regulatory announcements that do not fit other specific categories.
2025-01-29 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.